Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment
Objective: Chondroblastoma is a benign aggressive tumor which needs surgical treatment and has a recurrence rate up to 35%. Extended (aggressive) curettage is the mainstay of treatment and local adjuvants have been reported to decrease the recurrence rate. Methods: The recurrence rates and the funct...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2018-11-01
|
| Series: | Acta Orthopaedica et Traumatologica Turcica |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1017995X17304753 |
| _version_ | 1797908957332766720 |
|---|---|
| author | Devrim Özer Yavuz Arıkan Volkan Gür Cantay Gök Yunus Emre Akman |
| author_facet | Devrim Özer Yavuz Arıkan Volkan Gür Cantay Gök Yunus Emre Akman |
| author_sort | Devrim Özer |
| collection | DOAJ |
| description | Objective: Chondroblastoma is a benign aggressive tumor which needs surgical treatment and has a recurrence rate up to 35%. Extended (aggressive) curettage is the mainstay of treatment and local adjuvants have been reported to decrease the recurrence rate. Methods: The recurrence rates and the functional results of 14 patients who were treated in our institution and 2 other patients who were treated elsewhere between the years 2004–2016 were evaluated. Seventeen cases (13 male, 3 female; mean age: 17.1 [range: 13 to 32] years) who had been diagnosed, treated and followed up in our hospital between 2004 and 2016 were evaluated in terms of recurrence rates and functional outcomes. The average follow-up period was 41.6 (range: 12 to 132) months. Results: Five cases of recurrence were observed. Two cases had undergone their primary treatment in another institution. Seven cases were performed curettage alone whereas nine others were administered adjuvant treatments. One of the five recurrence patients was advised to undergo disarticulation. Another was treated with curettage and grafting and the remaining three patients with curettage and cementing. No recurrence was observed in their follow-up period. Their mean MSTS score was 27.3 (range: 4 to 30) over a maximum of 30 points and their functional results were good. Conclusion: Chondroblastoma is a tumor with high recurrence rates in the post-treatment period. However, good functional outcomes can be achieved with early diagnosis and appropriate treatment even after recurrence.Level of evidence: Level IV, therapeutic study. Keywords: Bone, Chondroblastoma, Recurrence, Treatment, Tumor |
| first_indexed | 2024-04-10T11:00:54Z |
| format | Article |
| id | doaj.art-5acbb43f035e47c4a86344c06b43be6c |
| institution | Directory Open Access Journal |
| issn | 1017-995X |
| language | English |
| last_indexed | 2024-04-10T11:00:54Z |
| publishDate | 2018-11-01 |
| publisher | AVES |
| record_format | Article |
| series | Acta Orthopaedica et Traumatologica Turcica |
| spelling | doaj.art-5acbb43f035e47c4a86344c06b43be6c2023-02-15T16:19:38ZengAVESActa Orthopaedica et Traumatologica Turcica1017-995X2018-11-01526415418Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatmentDevrim Özer0Yavuz Arıkan1Volkan Gür2Cantay Gök3Yunus Emre Akman4Department of Orthopedics and Traumatology, Metin Sabancı Baltalimanı Bone and Joint Diseases Training and Research Hospital, Istanbul, TurkeyDepartment of Orthopedics and Traumatology, Metin Sabancı Baltalimanı Bone and Joint Diseases Training and Research Hospital, Istanbul, Turkey; Corresponding author. Department of Orthopaedics and Traumatology, Metin Sabanci Baltalimani Bone Diseases Training and Research Hospital, Rumeli Hisari Street No: 62 34470, Baltalimani, Istanbul, Turkey. Tel.: +90 212 3237075/+90 505 398 34 34. Fax: +90 212 323 70 75.Department of Orthopedics and Traumatology, Metin Sabancı Baltalimanı Bone and Joint Diseases Training and Research Hospital, Istanbul, TurkeyDepartment of Radiology, Metin Sabancı Baltalimanı Bone and Joint Diseases Training and Research Hospital, Istanbul, TurkeyDepartment of Orthopedics and Traumatology, Metin Sabancı Baltalimanı Bone and Joint Diseases Training and Research Hospital, Istanbul, TurkeyObjective: Chondroblastoma is a benign aggressive tumor which needs surgical treatment and has a recurrence rate up to 35%. Extended (aggressive) curettage is the mainstay of treatment and local adjuvants have been reported to decrease the recurrence rate. Methods: The recurrence rates and the functional results of 14 patients who were treated in our institution and 2 other patients who were treated elsewhere between the years 2004–2016 were evaluated. Seventeen cases (13 male, 3 female; mean age: 17.1 [range: 13 to 32] years) who had been diagnosed, treated and followed up in our hospital between 2004 and 2016 were evaluated in terms of recurrence rates and functional outcomes. The average follow-up period was 41.6 (range: 12 to 132) months. Results: Five cases of recurrence were observed. Two cases had undergone their primary treatment in another institution. Seven cases were performed curettage alone whereas nine others were administered adjuvant treatments. One of the five recurrence patients was advised to undergo disarticulation. Another was treated with curettage and grafting and the remaining three patients with curettage and cementing. No recurrence was observed in their follow-up period. Their mean MSTS score was 27.3 (range: 4 to 30) over a maximum of 30 points and their functional results were good. Conclusion: Chondroblastoma is a tumor with high recurrence rates in the post-treatment period. However, good functional outcomes can be achieved with early diagnosis and appropriate treatment even after recurrence.Level of evidence: Level IV, therapeutic study. Keywords: Bone, Chondroblastoma, Recurrence, Treatment, Tumorhttp://www.sciencedirect.com/science/article/pii/S1017995X17304753 |
| spellingShingle | Devrim Özer Yavuz Arıkan Volkan Gür Cantay Gök Yunus Emre Akman Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment Acta Orthopaedica et Traumatologica Turcica |
| title | Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment |
| title_full | Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment |
| title_fullStr | Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment |
| title_full_unstemmed | Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment |
| title_short | Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment |
| title_sort | chondroblastoma an evaluation of the recurrences and functional outcomes following treatment |
| url | http://www.sciencedirect.com/science/article/pii/S1017995X17304753 |
| work_keys_str_mv | AT devrimozer chondroblastomaanevaluationoftherecurrencesandfunctionaloutcomesfollowingtreatment AT yavuzarıkan chondroblastomaanevaluationoftherecurrencesandfunctionaloutcomesfollowingtreatment AT volkangur chondroblastomaanevaluationoftherecurrencesandfunctionaloutcomesfollowingtreatment AT cantaygok chondroblastomaanevaluationoftherecurrencesandfunctionaloutcomesfollowingtreatment AT yunusemreakman chondroblastomaanevaluationoftherecurrencesandfunctionaloutcomesfollowingtreatment |